awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35793176-1986AAE7-9141-4902-9FF9-446D9AFEE0B1
Q35793176-1986AAE7-9141-4902-9FF9-446D9AFEE0B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35793176-1986AAE7-9141-4902-9FF9-446D9AFEE0B1
A phase I study of midostaurin and azacitidine in relapsed and elderly AML patients
P2860
Q35793176-1986AAE7-9141-4902-9FF9-446D9AFEE0B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35793176-1986AAE7-9141-4902-9FF9-446D9AFEE0B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0194708c5077e5804f2e2eec97f242c50939f801
P2860
Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.